{"id":17514,"date":"2026-02-17T15:29:10","date_gmt":"2026-02-17T20:29:10","guid":{"rendered":"https:\/\/eczemahelp.ca\/?p=17514"},"modified":"2026-02-17T15:29:14","modified_gmt":"2026-02-17T20:29:14","slug":"un-medecin-vous-parle-de-dupixent-dupilumab","status":"publish","type":"post","link":"https:\/\/eczemahelp.ca\/fr\/un-medecin-vous-parle-de-dupixent-dupilumab\/","title":{"rendered":"Un m\u00e9decin vous parle de Dupixent\u00ae (dupilumab)"},"content":{"rendered":"<h2>Apprenez-en plus sur un m\u00e9dicament biologique contre la dermatite atopique : point de vue de la D<sup>re<\/sup> Rachel Asiniwasis, dermatologue<\/h2>\n<p><span style=\"font-weight: 400;\">La Soci\u00e9t\u00e9 canadienne de l\u2019ecz\u00e9ma a demand\u00e9 \u00e0 la D<\/span><span style=\"font-weight: 400;\"><sup>re<\/sup><\/span><span style=\"font-weight: 400;\">\u00a0Rachel Asiniwasis (FRCPC), dermatologue et chercheuse, de nous faire part de son expertise au sujet de Dupixent<\/span><span style=\"font-weight: 400;\">\u00ae<\/span><span style=\"font-weight: 400;\"> (dupilumab), un m\u00e9dicament biologique, et de la mani\u00e8re dont il est utilis\u00e9 pour prendre en charge la dermatite atopique (DA), soit la forme la plus courante d\u2019ecz\u00e9ma.<\/span><\/p>\n<h2>Que sont les m\u00e9dicaments biologiques?<\/h2>\n<p><span style=\"font-weight: 400;\">Les m\u00e9dicaments \u2013 ou agents \u2013 biologiques n\u2019agissent pas de la m\u00eame mani\u00e8re que les traitements classiques de la DA; ils ciblent des composantes pr\u00e9cises du syst\u00e8me immunitaire qui peuvent causer la maladie. Pour mettre au point des m\u00e9dicaments biologiques, les scientifiques produisent des prot\u00e9ines \u00e0 partir de tissus vivants ou de cellules cultiv\u00e9es en laboratoire. De nombreux m\u00e9dicaments biologiques sont approuv\u00e9s au Canada pour le traitement de la DA. Un traitement avanc\u00e9 de la DA, comme les m\u00e9dicaments biologiques, peut entra\u00eener la disparition compl\u00e8te des l\u00e9sions cutan\u00e9es et att\u00e9nuer consid\u00e9rablement les d\u00e9mangeaisons et les \u00e9ruptions.<\/span><\/p>\n<h2>Comment Dupixent\u00ae agit-il?<\/h2>\n<p><span style=\"font-weight: 400;\">Dupixent<\/span><span style=\"font-weight: 400;\">\u00ae<\/span><span style=\"font-weight: 400;\"> agit en bloquant certaines prot\u00e9ines, en l\u2019occurrence les interleukines (IL-4 et IL-13), qui peuvent d\u00e9clencher l\u2019inflammation associ\u00e9e \u00e0 la DA dans l\u2019organisme. Il permet donc de r\u00e9duire l\u2019inflammation et de soulager les signes et les sympt\u00f4mes comme les d\u00e9mangeaisons, la rougeur et les \u00e9ruptions cutan\u00e9es. Dupixent est \u00e9galement indiqu\u00e9 pour traiter d\u2019autres affections li\u00e9es \u00e0 la DA, comme l\u2019asthme, l\u2019\u0153sophagite \u00e0 \u00e9osinophiles, le prurigo nodulaire et la rhinosinusite chronique avec polypes nasaux.<\/span><\/p>\n<h2>\u00c0 qui Dupixent\u00ae convient-il?<\/h2>\n<p><span style=\"font-weight: 400;\">Dupixent<\/span><span style=\"font-weight: 400;\">\u00ae<\/span><span style=\"font-weight: 400;\"> est approuv\u00e9 pour les adultes et les enfants \u00e2g\u00e9s de 6\u00a0mois ou plus atteints de DA mod\u00e9r\u00e9e ou s\u00e9v\u00e8re <\/span><span style=\"font-weight: 400;\">chez qui la maladie n\u2019est pas ad\u00e9quatement ma\u00eetris\u00e9e par des traitements topiques sous ordonnance ou quand ces traitements ne sont pas appropri\u00e9s. <\/span><span style=\"font-weight: 400;\">Dupixent<\/span><span style=\"font-weight: 400;\">\u00ae<\/span> <span style=\"font-weight: 400;\">peut \u00eatre utilis\u00e9 avec ou sans corticost\u00e9ro\u00efdes topiques<sup>1<\/sup><\/span><span style=\"font-weight: 400;\">.<\/span><\/p>\n<h2>Comment Dupixent\u00ae s\u2019administre-t-il?<\/h2>\n<p><span style=\"font-weight: 400;\">Dupixent<\/span><span style=\"font-weight: 400;\">\u00ae<\/span><span style=\"font-weight: 400;\"> est administr\u00e9 par injection sous-cutan\u00e9e (sous la peau). Les patients doivent utiliser ce m\u00e9dicament exactement de la mani\u00e8re prescrite par leur professionnel de la sant\u00e9.<\/span><\/p>\n<h2>Que faire si ma dermatite atopique ne s\u2019att\u00e9nue pas?<\/h2>\n<p><span style=\"font-weight: 400;\">Si vous constatez que votre DA ne r\u00e9pond pas \u00e0 ce m\u00e9dicament, informez-en votre m\u00e9decin. Si vous avez des questions concernant votre plan de traitement ou celui de votre enfant, n\u2019h\u00e9sitez pas \u00e0 en parler \u00e0 un professionnel de la sant\u00e9 qualifi\u00e9, comme un dermatologue.<\/span><\/p>\n<h2>Quels sont les effets secondaires courants de ce m\u00e9dicament?<\/h2>\n<p><span style=\"font-weight: 400;\">Tous les m\u00e9dicaments sont associ\u00e9s \u00e0 des risques et \u00e0 des bienfaits, qui doivent \u00eatre pass\u00e9s en revue avec le professionnel de la sant\u00e9 prescripteur. Les <\/span><span style=\"font-weight: 400;\">effets secondaires signal\u00e9s le plus souvent sont notamment les r\u00e9actions au point d\u2019injection et une inflammation des yeux et des paupi\u00e8res (rougeur, enflure, d\u00e9mangeaisons et\/ou s\u00e9cheresse). Dans la pratique clinique r\u00e9elle, la plupart des cas sont l\u00e9gers et se traitent facilement. Pour obtenir plus de renseignements, veuillez consulter la monographie. Si vous ou votre enfant pr\u00e9sentez ces effets secondaires ou si vous avez la moindre <\/span><span style=\"font-weight: 400;\">pr\u00e9occupation au sujet de ce <\/span><span style=\"font-weight: 400;\">traitement, consultez le professionnel de la sant\u00e9 qui vous l\u2019a prescrit.<\/span><\/p>\n<h2>Que faire si ma dermatite atopique ne s\u2019att\u00e9nue pas?<\/h2>\n<p><span style=\"font-weight: 400;\">Si vous pensez que votre DA ne r\u00e9pond pas au traitement, informez-en votre m\u00e9decin. Il se peut que votre plan de traitement doive \u00eatre modifi\u00e9. Un professionnel de la sant\u00e9 qualifi\u00e9, comme un dermatologue, peut r\u00e9\u00e9valuer votre maladie ou celle de votre enfant et \u00e9ventuellement revoir le plan de traitement. Il n\u2019existe pas de traitement curatif de la DA, mais il y a d\u00e9sormais de nombreux traitements pour aider les patients.<\/span><\/p>\n<p>La Soci\u00e9t\u00e9 canadienne de l\u2019ecz\u00e9ma remercie la D<sup>re<\/sup>\u00a0Rachel Asiniwasis (MSHS, FRCPC, FAAD) de sa contribution volontaire \u00e0 ce contenu \u00e9ducatif.<\/p>\n<p><span style=\"font-weight: 400;\"><strong>R\u00e9f\u00e9rence <\/strong>: <\/span><span style=\"font-weight: 400;\"><sup>1 <\/sup><\/span><span style=\"font-weight: 400;\">sanofi-aventis Canada Inc. (novembre\u00a02024). <a href=\"https:\/\/www.sanofi.com\/assets\/countries\/canada\/docs\/products\/prescription-products\/dupixent-fr.pdf\">Monographie de Dupixent<\/a><\/span><a href=\"https:\/\/www.sanofi.com\/assets\/countries\/canada\/docs\/products\/prescription-products\/dupixent-fr.pdf\"><b>\u00ae<\/b><\/a><a href=\"https:\/\/www.sanofi.com\/assets\/countries\/canada\/docs\/products\/prescription-products\/dupixent-fr.pdf\"><span style=\"font-weight: 400;\"> (<\/span><span style=\"font-weight: 400;\">dupilumab<\/span><\/a><span style=\"font-weight: 400;\"><a href=\"https:\/\/www.sanofi.com\/assets\/countries\/canada\/docs\/products\/prescription-products\/dupixent-fr.pdf\">)<\/a><a href=\"https:\/\/www.sanofi.com\/assets\/countries\/canada\/docs\/products\/prescription-products\/dupixent-fr.pdf\">, solution pour injection sous-cutan\u00e9e<\/a>.\u00a0<\/span><\/p>\n<p><i><span style=\"font-weight: 400;\">Avis de non-responsabilit\u00e9\u00a0: L\u2019information contenue dans cette ressource ne remplace pas les conseils d\u2019un m\u00e9decin et ne doit pas servir d\u2019outil diagnostique. L\u2019information \u00e9tait \u00e0 jour \u00e0 la date de publication. Les interventions, les m\u00e9dicaments et les plans de traitement sont tous associ\u00e9s \u00e0 des risques et \u00e0 des bienfaits. Il est donc important de discuter de ses besoins particuliers ou de ceux de son enfant avec un professionnel de la sant\u00e9 qualifi\u00e9.<\/span><\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Apprenez-en plus sur un m\u00e9dicament biologique contre la dermatite atopique : point de vue de la Dre Rachel Asiniwasis, dermatologue La Soci\u00e9t\u00e9 canadienne de l\u2019ecz\u00e9ma a demand\u00e9 \u00e0 la Dre\u00a0Rachel Asiniwasis (FRCPC), dermatologue et chercheuse, de nous faire part de son expertise au sujet de Dupixent\u00ae (dupilumab), un m\u00e9dicament biologique, et de la mani\u00e8re dont [&hellip;]<\/p>\n","protected":false},"author":21,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[53],"tags":[],"class_list":["post-17514","post","type-post","status-publish","format-standard","hentry","category-traitements"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Un m\u00e9decin vous parle de Dupixent\u00ae (dupilumab) | Eczema Society of Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eczemahelp.ca\/ask-the-doctor-about-dupixent-dupilumab\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un m\u00e9decin vous parle de Dupixent\u00ae (dupilumab) | Eczema Society of Canada\" \/>\n<meta property=\"og:description\" content=\"Apprenez-en plus sur un m\u00e9dicament biologique contre la dermatite atopique : point de vue de la Dre Rachel Asiniwasis, dermatologue La Soci\u00e9t\u00e9 canadienne de l\u2019ecz\u00e9ma a demand\u00e9 \u00e0 la Dre\u00a0Rachel Asiniwasis (FRCPC), dermatologue et chercheuse, de nous faire part de son expertise au sujet de Dupixent\u00ae (dupilumab), un m\u00e9dicament biologique, et de la mani\u00e8re dont [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eczemahelp.ca\/ask-the-doctor-about-dupixent-dupilumab\/\" \/>\n<meta property=\"og:site_name\" content=\"Eczema Society of Canada\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/EczemaSocietyofCanada\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-17T20:29:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-17T20:29:14+00:00\" \/>\n<meta name=\"author\" content=\"support@1dea.ca\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@EczemaSocietyCA\" \/>\n<meta name=\"twitter:site\" content=\"@EczemaSocietyCA\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"support@1dea.ca\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/ask-the-doctor-about-dupixent-dupilumab\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/ask-the-doctor-about-dupixent-dupilumab\\\/\"},\"author\":{\"name\":\"support@1dea.ca\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#\\\/schema\\\/person\\\/49d21625952d7bdf0988f82470cacc00\"},\"headline\":\"Un m\u00e9decin vous parle de Dupixent\u00ae (dupilumab)\",\"datePublished\":\"2026-02-17T20:29:10+00:00\",\"dateModified\":\"2026-02-17T20:29:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/ask-the-doctor-about-dupixent-dupilumab\\\/\"},\"wordCount\":784,\"publisher\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#organization\"},\"articleSection\":[\"Traitements\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/ask-the-doctor-about-dupixent-dupilumab\\\/\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/ask-the-doctor-about-dupixent-dupilumab\\\/\",\"name\":\"Un m\u00e9decin vous parle de Dupixent\u00ae (dupilumab) | Eczema Society of Canada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#website\"},\"datePublished\":\"2026-02-17T20:29:10+00:00\",\"dateModified\":\"2026-02-17T20:29:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/ask-the-doctor-about-dupixent-dupilumab\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/eczemahelp.ca\\\/ask-the-doctor-about-dupixent-dupilumab\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/ask-the-doctor-about-dupixent-dupilumab\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/eczemahelp.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Un m\u00e9decin vous parle de Dupixent\u00ae (dupilumab)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#website\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/\",\"name\":\"Eczema Society of Canada\",\"description\":\"Educational Resources\",\"publisher\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/eczemahelp.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#organization\",\"name\":\"Eczema Society of Canada\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/logo.png\",\"width\":362,\"height\":360,\"caption\":\"Eczema Society of Canada\"},\"image\":{\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/EczemaSocietyofCanada\",\"https:\\\/\\\/x.com\\\/EczemaSocietyCA\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/EczemaHelp\",\"https:\\\/\\\/www.instagram.com\\\/eczemasocietyofcanada\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/#\\\/schema\\\/person\\\/49d21625952d7bdf0988f82470cacc00\",\"name\":\"support@1dea.ca\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/litespeed\\\/avatar\\\/97a3c8069c1b8c15f712e101b8d9ab1a.jpg?ver=1776185502\",\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/litespeed\\\/avatar\\\/97a3c8069c1b8c15f712e101b8d9ab1a.jpg?ver=1776185502\",\"contentUrl\":\"https:\\\/\\\/eczemahelp.ca\\\/wp-content\\\/litespeed\\\/avatar\\\/97a3c8069c1b8c15f712e101b8d9ab1a.jpg?ver=1776185502\",\"caption\":\"support@1dea.ca\"},\"url\":\"https:\\\/\\\/eczemahelp.ca\\\/fr\\\/author\\\/support1dea-ca\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un m\u00e9decin vous parle de Dupixent\u00ae (dupilumab) | Eczema Society of Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eczemahelp.ca\/ask-the-doctor-about-dupixent-dupilumab\/","og_locale":"fr_FR","og_type":"article","og_title":"Un m\u00e9decin vous parle de Dupixent\u00ae (dupilumab) | Eczema Society of Canada","og_description":"Apprenez-en plus sur un m\u00e9dicament biologique contre la dermatite atopique : point de vue de la Dre Rachel Asiniwasis, dermatologue La Soci\u00e9t\u00e9 canadienne de l\u2019ecz\u00e9ma a demand\u00e9 \u00e0 la Dre\u00a0Rachel Asiniwasis (FRCPC), dermatologue et chercheuse, de nous faire part de son expertise au sujet de Dupixent\u00ae (dupilumab), un m\u00e9dicament biologique, et de la mani\u00e8re dont [&hellip;]","og_url":"https:\/\/eczemahelp.ca\/ask-the-doctor-about-dupixent-dupilumab\/","og_site_name":"Eczema Society of Canada","article_publisher":"https:\/\/www.facebook.com\/EczemaSocietyofCanada","article_published_time":"2026-02-17T20:29:10+00:00","article_modified_time":"2026-02-17T20:29:14+00:00","author":"support@1dea.ca","twitter_card":"summary_large_image","twitter_creator":"@EczemaSocietyCA","twitter_site":"@EczemaSocietyCA","twitter_misc":{"\u00c9crit par":"support@1dea.ca","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/eczemahelp.ca\/ask-the-doctor-about-dupixent-dupilumab\/#article","isPartOf":{"@id":"https:\/\/eczemahelp.ca\/ask-the-doctor-about-dupixent-dupilumab\/"},"author":{"name":"support@1dea.ca","@id":"https:\/\/eczemahelp.ca\/#\/schema\/person\/49d21625952d7bdf0988f82470cacc00"},"headline":"Un m\u00e9decin vous parle de Dupixent\u00ae (dupilumab)","datePublished":"2026-02-17T20:29:10+00:00","dateModified":"2026-02-17T20:29:14+00:00","mainEntityOfPage":{"@id":"https:\/\/eczemahelp.ca\/ask-the-doctor-about-dupixent-dupilumab\/"},"wordCount":784,"publisher":{"@id":"https:\/\/eczemahelp.ca\/#organization"},"articleSection":["Traitements"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/eczemahelp.ca\/ask-the-doctor-about-dupixent-dupilumab\/","url":"https:\/\/eczemahelp.ca\/ask-the-doctor-about-dupixent-dupilumab\/","name":"Un m\u00e9decin vous parle de Dupixent\u00ae (dupilumab) | Eczema Society of Canada","isPartOf":{"@id":"https:\/\/eczemahelp.ca\/#website"},"datePublished":"2026-02-17T20:29:10+00:00","dateModified":"2026-02-17T20:29:14+00:00","breadcrumb":{"@id":"https:\/\/eczemahelp.ca\/ask-the-doctor-about-dupixent-dupilumab\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eczemahelp.ca\/ask-the-doctor-about-dupixent-dupilumab\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/eczemahelp.ca\/ask-the-doctor-about-dupixent-dupilumab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/eczemahelp.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Un m\u00e9decin vous parle de Dupixent\u00ae (dupilumab)"}]},{"@type":"WebSite","@id":"https:\/\/eczemahelp.ca\/#website","url":"https:\/\/eczemahelp.ca\/","name":"Eczema Society of Canada","description":"Educational Resources","publisher":{"@id":"https:\/\/eczemahelp.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eczemahelp.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/eczemahelp.ca\/#organization","name":"Eczema Society of Canada","url":"https:\/\/eczemahelp.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/eczemahelp.ca\/#\/schema\/logo\/image\/","url":"https:\/\/eczemahelp.ca\/wp-content\/uploads\/2023\/06\/logo.png","contentUrl":"https:\/\/eczemahelp.ca\/wp-content\/uploads\/2023\/06\/logo.png","width":362,"height":360,"caption":"Eczema Society of Canada"},"image":{"@id":"https:\/\/eczemahelp.ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/EczemaSocietyofCanada","https:\/\/x.com\/EczemaSocietyCA","https:\/\/www.youtube.com\/user\/EczemaHelp","https:\/\/www.instagram.com\/eczemasocietyofcanada\/"]},{"@type":"Person","@id":"https:\/\/eczemahelp.ca\/#\/schema\/person\/49d21625952d7bdf0988f82470cacc00","name":"support@1dea.ca","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/eczemahelp.ca\/wp-content\/litespeed\/avatar\/97a3c8069c1b8c15f712e101b8d9ab1a.jpg?ver=1776185502","url":"https:\/\/eczemahelp.ca\/wp-content\/litespeed\/avatar\/97a3c8069c1b8c15f712e101b8d9ab1a.jpg?ver=1776185502","contentUrl":"https:\/\/eczemahelp.ca\/wp-content\/litespeed\/avatar\/97a3c8069c1b8c15f712e101b8d9ab1a.jpg?ver=1776185502","caption":"support@1dea.ca"},"url":"https:\/\/eczemahelp.ca\/fr\/author\/support1dea-ca\/"}]}},"_links":{"self":[{"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/posts\/17514","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/comments?post=17514"}],"version-history":[{"count":4,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/posts\/17514\/revisions"}],"predecessor-version":[{"id":18814,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/posts\/17514\/revisions\/18814"}],"wp:attachment":[{"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/media?parent=17514"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/categories?post=17514"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eczemahelp.ca\/fr\/wp-json\/wp\/v2\/tags?post=17514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}